国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
15期
2303-2305
,共3页
宫腔镜%瘢痕妊娠%甲氨蝶呤(MTX)
宮腔鏡%瘢痕妊娠%甲氨蝶呤(MTX)
궁강경%반흔임신%갑안접령(MTX)
Hysteroscopy%Cesarean scar pregnancy%Methotrexate
目的 探讨宫腔镜病灶切除术联合甲氨蝶呤(MTX)、米非司酮在治疗剖宫产术后子宫瘢痕妊娠(CSP)中的临床疗效.方法 回顾性分析2009年10月到2013年10月期间收治的32例经阴道彩超确诊为早期CSP患者,按照治疗方法的不同随机平均分为两组.A组为对照组,采用MTX囊内注射,联合米非司酮口服,1周后在B超监测下行清宫术;B组为实验组,采用MTX囊内注射,联合米非司酮口服治疗,1周后在B超监测下行宫腔镜病灶切除术+清宫术+ MTX病灶注射.对比两组病人治疗后阴道流血量、血β-HCG下降情况及正常月经来潮时间,比较两组的疗效.结果 治疗后1周两组血β-HCG均明显下降,达到50%以上,但B组下降幅度比A组明显;B组血β-HCG下降到正常的时间(14.0±5.1)天及正常月经来潮时间(30.0±4.4)天均比A组短,无一例并发症出现.结论 宫腔镜病灶切除术联合MTX治疗CSP较单独使用药物+普通清宫术效果更好.
目的 探討宮腔鏡病竈切除術聯閤甲氨蝶呤(MTX)、米非司酮在治療剖宮產術後子宮瘢痕妊娠(CSP)中的臨床療效.方法 迴顧性分析2009年10月到2013年10月期間收治的32例經陰道綵超確診為早期CSP患者,按照治療方法的不同隨機平均分為兩組.A組為對照組,採用MTX囊內註射,聯閤米非司酮口服,1週後在B超鑑測下行清宮術;B組為實驗組,採用MTX囊內註射,聯閤米非司酮口服治療,1週後在B超鑑測下行宮腔鏡病竈切除術+清宮術+ MTX病竈註射.對比兩組病人治療後陰道流血量、血β-HCG下降情況及正常月經來潮時間,比較兩組的療效.結果 治療後1週兩組血β-HCG均明顯下降,達到50%以上,但B組下降幅度比A組明顯;B組血β-HCG下降到正常的時間(14.0±5.1)天及正常月經來潮時間(30.0±4.4)天均比A組短,無一例併髮癥齣現.結論 宮腔鏡病竈切除術聯閤MTX治療CSP較單獨使用藥物+普通清宮術效果更好.
목적 탐토궁강경병조절제술연합갑안접령(MTX)、미비사동재치료부궁산술후자궁반흔임신(CSP)중적림상료효.방법 회고성분석2009년10월도2013년10월기간수치적32례경음도채초학진위조기CSP환자,안조치료방법적불동수궤평균분위량조.A조위대조조,채용MTX낭내주사,연합미비사동구복,1주후재B초감측하행청궁술;B조위실험조,채용MTX낭내주사,연합미비사동구복치료,1주후재B초감측하행궁강경병조절제술+청궁술+ MTX병조주사.대비량조병인치료후음도류혈량、혈β-HCG하강정황급정상월경래조시간,비교량조적료효.결과 치료후1주량조혈β-HCG균명현하강,체도50%이상,단B조하강폭도비A조명현;B조혈β-HCG하강도정상적시간(14.0±5.1)천급정상월경래조시간(30.0±4.4)천균비A조단,무일례병발증출현.결론 궁강경병조절제술연합MTX치료CSP교단독사용약물+보통청궁술효과경호.
Objective To explore the clinical efficacy of hysteroscopic resection of lesions combined with methotrexate (MTX) and mifepristone in the treatment of cesarean scar pregnancy (CSP).Methods 32 women with early CSP diagnosed by transvaginal color Doppler ultrasound who had been treated in our hospital during from October 2009 to October 2013 were retrospectively analyzed.The women were randomly divided into two groups according to different therapies.Group A (control group) received dilatation and curettage under type B-ultrasonic monitoring one week after treatment with intracapsular infusions of MTX combined with oral mifepristone; whereas group B (study group) received hysteroscopic resection of lesions plus dilatation and curettage and intralesional injections under ultrasonic monitoring one week following therapies with intracapsular infusions of MTX combined with oral mifepristone.The amount of vaginal bleeding and the decrease in blood B-HCG after treatment,time to onset of the menstrual cycle,and efficacy of therapies were compared between the two groups.Results One week after treatment,B-HCG level was markedly declined in both groups,which was more than 50% of the baseline.The percentage of B-HCG decrease was significantly greater,and time to return of B-HCG to normal level and to return of a normal menstrual cycle was shorter in group B [(14.0 ± 5.1) days and (30.00 ± 4.40)days] than in those in group A.No complications occurred.Conclusions Hysteroscopic resection of lesions combined with methotrexate is more effective than medication alone in the treatment of cesarean scar pregnancy.